Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 81-100 of 149

Title Anticipated publication date Referral date Process
Prostate cancer - intensity modulated radiotherapy [ID17] TBC Mar 2008 MTA
Psoriasis - briakinumab (suspended) [ID65] TBC Nov 2008 STA
Psoriatic arthritis (moderate to severe) - leflunomide [ID391] TBC Nov 2005 STA
Pulmonary arterial hypertension (adults) - drugs [ID12] TBC Apr 2005 MTA
Renal transplantation (children, adolescents) - immunosuppressive regimens (review of TA99) [ID346] TBC MTA
Rheumatoid arthritis (after the failure of conventional DMARDs) -rituximab [ID333] TBC Apr 2010 STA
Rheumatoid arthritis - adalimumab, etanercept and infliximab (sequential use) [ID18] TBC Jun 2004 MTA
Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537] TBC MTA
Rheumatoid arthritis - tofacitinib [ID526] TBC May 2012 STA
Soft tissue or bone sarcoma (metastatic) - ridaforolimus (maintenance) [ID415] TBC Sep 2011 STA
Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416] TBC Nov 2010 STA
Systemic lupus erythematosus - prasterone [ID392] TBC Oct 2000 MTA
T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin [ID504] TBC Nov 2011 STA
Thrombophilia [ID393] TBC Oct 2000 MTA
Venous leg ulcers - new treatments [ID394] TBC Jun 2003 MTA
Venous thromboembolism (prevention) - rivaroxaban [ID463] TBC May 2011 STA
Venous thromboembolism (recurrent) - idraparinux sodium [ID395] TBC Nov 2005 STA
Venous thromboembolism (VTE) - ximelagatran [ID396] TBC Oct 2000 MTA
Venous thromboembolism - apixaban (acute medical illness) [ID310] TBC Jan 2010 STA
Renal cell carcinoma (second line metastatic) - pazopanib [ID70] Jan 2011 Nov 2008 STA

This page was last updated: 22 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.